文献速递重症综合管理与镇静镇痛儿科与产科急症呼吸衰竭与机械通气

体外膜肺氧合在危重孕产妇救治中的应用

[Application of extracorporeal membrane oxygenation in critically ill pregnant women].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论回顾性分析8例危重孕产妇使用ECMO的经验:可逆性严重心肺功能障碍者尽早评估ECMO可能改善母婴生存,但肺动脉高压患者预后差。

5例重症肺炎接受VV-ECMO,3例心衰接受VA-ECMO,初始流量2.0-3.0 L/min,最高流量(3.1±0.6)L/min,平均运行(174±36)小时,ICU住院(16.0±5.4)天。6例成功撤离ECMO并存活,2例肺动脉高压患者预后差;7名婴儿存活。无严重出血并发症,1例发生肝素诱导的血小板减少症伴血栓形成(HITT)后更换抗凝治疗,1例因穿刺血管血栓接受序贯抗凝治疗3个月。结论认为对可逆性严重心肺功能障碍的危重孕产妇应尽早评估ECMO应用以提高母婴生存率。

要点

  • 8例危重孕产妇中5例重症肺炎用VV-ECMO、3例心衰用VA-ECMO,初始流量2.0-3.0 L/min,最高流量(3.1±0.6)L/min。
  • 6例(5例重症肺炎和1例围产期心肌病)成功撤离ECMO并存活,2例肺动脉高压患者预后差。
  • 8例中7名婴儿存活,其中2例在撤离ECMO后分娩,1例在ECMO支持下急诊剖宫产,1例因孕周不足未能分娩。
  • ECMO期间无严重出血并发症,1例发生HITT后更换抗凝治疗,1例因穿刺血管血栓接受序贯抗凝治疗3个月。
  • 对可逆性严重心肺功能障碍的危重孕产妇,应尽早评估ECMO应用以提高母婴生存率。

适用人群与场景

  • 原文未明确列出排除标准。

诊断标准与关键阈值

  • 原文未提及具体的ECMO启动标准或评分界值。
  • 原文报告APACHE II评分为13.0±6.6,SOFA评分为8.3±3.8(为研究人群基线描述,非启动阈值)。

处置流程与药物剂量

  • 第一步:对可逆性严重心肺功能障碍的危重孕产妇尽早评估ECMO应用。
  • 第二步:根据病因选择模式——重症肺炎5例采用静脉-静脉ECMO(VV-ECMO),心衰3例采用静脉-动脉ECMO(VA-ECMO)。
  • 第三步:ECMO初始流量设置为2.0-3.0 L/min,最高流量(3.1±0.6)L/min,平均运行时间(174±36)小时。
  • 抗凝相关处理:1例发生肝素诱导的血小板减少症伴血栓形成(HITT)后接受另一种抗凝治疗;1例因穿刺血管血栓接受序贯抗凝治疗3个月。
  • 产科处理:2例在撤离ECMO后分娩,1例在ECMO支持下急诊剖宫产,1例因孕周不足未能分娩。

红旗征与不能漏的情况

  • 肺动脉高压患者预后差:2例肺动脉高压孕产妇虽经ECMO治疗仍预后不良。
  • 肝素诱导的血小板减少症伴血栓形成(HITT):1例发生,需更换抗凝治疗。
  • 穿刺血管血栓:1例发生,需序贯抗凝治疗3个月。

研究设计与关键结果

  • 人群基线:平均年龄(32.5±6.3)岁,体重(73.5±8.1)kg,孕周(31.0±4.4)周,APACHE II评分13.0±6.6,SOFA评分8.3±3.8。
  • 干预:5例重症肺炎接受VV-ECMO,3例心衰接受VA-ECMO;初始流量2.0-3.0 L/min,最高流量(3.1±0.6)L/min,平均运行(174±36)小时,ICU住院(16.0±5.4)天。
  • 主要结局:6例(5例重症肺炎和1例围产期心肌病)成功撤离ECMO并存活;2例肺动脉高压患者预后差。
  • 母婴结局:7名婴儿存活;2例撤离ECMO后分娩,1例ECMO支持下急诊剖宫产,1例因孕周不足未能分娩。
  • 不良事件:无严重出血并发症;1例发生HITT后更换抗凝治疗;1例因穿刺血管血栓接受序贯抗凝治疗3个月。

证据类型、等级与局限

  • 证据类型:单中心回顾性病例分析(8例),非随机对照研究。
  • 局限:样本量小(8例)、单中心、回顾性设计,无对照组,结论需前瞻性研究验证。

对床旁实践的改变

  • 对围产期可逆性严重心肺功能障碍的危重孕产妇,应尽早评估ECMO应用,而非等到病情不可逆时再考虑。
  • 重症肺炎可考虑VV-ECMO,心衰可考虑VA-ECMO;初始流量可设置为2.0-3.0 L/min(本研究方案,非通用推荐)。
  • 肺动脉高压孕产妇即使使用ECMO预后仍可能很差,需提前与家属沟通并做好预案。
  • ECMO期间需警惕HITT和穿刺血管血栓,前者需更换抗凝治疗,后者可能需要序贯抗凝治疗3个月(本研究做法)。

指南或共识出处

  • 原文未提及指南或共识名称;本文为单中心回顾性研究(Zhonghua Wei Zhong Bing Ji Jiu Yi Xue)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the safety and effectiveness of extracorporeal membrane oxygenation (ECMO) in emergency treatment of critically ill pregnant women.

METHODS: Clinical data of 8 pregnant women with severe cardiopulmonary dysfunction during the perinatal period treated by ECMO in the department of intensive care unit (ICU) of Nanjing Drum Tower Hospital, the Affiliated Hospital to Nanjing University Medical School from September 2017 to November 2020 were retrospectively analyzed.

RESULTS: For the 8 pregnant women, the mean age was (32.5±6.3) years old. Body weight was (73.5±8.1) kg. Gestational age was (31.0±4.4) weeks. Acute physiology and chronic health evaluation II (APACHE II) score was 13.0±6.6, and sequential organ failure assessment (SOFA) score was 8.3±3.8. Among them, 5 pregnant women suffered from severe pneumonia and were treated with venous-venous ECMO (VV-ECMO). Another 3 pregnant women with heart failure underwent venous-arterial ECMO (VA-ECMO). The initial ECMO flow rate was set to 2.0-3.0 L/min. Then the highest flow rate was (3.1±0.6) L/min, and the average ECMO running time was (174±36) hours. The length of ICU stay was (16.0±5.4) days. Six pregnant women (5 with severe pneumonia and 1 with peripartum cardiomyopathy) successfully evacuated from ECMO and survived. Two pregnant women with pulmonary hypertension showed poor prognosis. In total, seven babies survived. Two of them were delivered after ECMO evacution, and one underwent emergency cesarean section with ECMO support. In another case, the fetus could not be delivered due to under-gestational weeks. During this period, there were no serious bleeding complications. One pregnant woman developed heparin-induced thrombocytopenia and thrombosis (HITT), then she received another anticoagulant treatment. One pregnant woman got sequential anticoagulation therapy for 3 months on account of thrombosis in the puncture vessel.

CONCLUSIONS: ECMO has played an active role in the rescue of critically ill pregnant women. For those with reversible severe cardiopulmonary dysfunction, it is necessary to evaluate the application of ECMO as early as possible to improve the survival rate of mothers and infants.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Qian Y, Hao Y, Liu Y, et al. [Application of extracorporeal membrane oxygenation in critically ill pregnant women]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34112302. doi:10.3760/cma.j.cn121430-20201231-00784

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。